Pfizer has reported a narrower-than-expected adjusted loss for the third quarter, but it faces challenges related to its Covid antiviral treatment Paxlovid and the Covid vaccine. The company recorded a $5.6 billion charge for inventory write-offs in the third quarter due to lower-than-expected use of Covid products, with $4.7 billion attributed to Paxlovid and $900… Continue reading Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs

Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) (“Justera” or the “Company“) is pleased to announce that the Company’s wholly-owned subsidiary, Naturevan Nutrition Ltd., (“Naturevan“), has entered into an agreement to supply to Costco Korea through its distributor, JS Foods Global (“JS Foods“), a health food distributor with operations spanning the U.S.A., South Korea, Japan,… Continue reading Justera Health Announces Supply Agreement for Costco Korea

The article details a planned walkout by some pharmacy staff from Walgreens and other major drugstore chains to protest what they perceive as unsafe working conditions jeopardizing both employees and patients. Dubbed “Pharmageddon,” the walkout, set to occur over three days, seeks to prompt substantial changes addressing ongoing grievances. Organizers and employees cite understaffing, inadequate… Continue reading Some pharmacy staff from Walgreens, other chains are walking out again — here’s what you need to know

The article highlights the growing concerns of pharmacy employees at major U.S. drugstore chains, such as Walgreens and CVS, who are grappling with increasing workloads, understaffing, and cuts to their hours. Here are the key points from the article: 1. Overworked and Understaffed Pharmacy Employees: 2. Walkouts and Protests: 3. Workday Challenges for Pharmacy Employees:… Continue reading Pharmacy staff from Walgreens, CVS say they’re at a breaking point — here’s what their days look like

Bristol Myers Squibb reported its third-quarter earnings, which surpassed expectations for adjusted earnings per share but met revenue estimates. The company’s revenue for the quarter reached $10.96 billion, a 2% decrease from the same period last year. This decline was mainly attributed to reduced sales of the blood cancer drug Revlimid, which brought in $1.43… Continue reading Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competition

Pfizer and its partner BioNTech are moving forward with a combination vaccine for Covid-19 and the flu. Positive initial results from an early to mid-stage study have paved the way for the vaccine to enter a final-stage trial in the coming months. The pharmaceutical giant hopes to gain regulatory approval for this combination shot in… Continue reading Pfizer’s combination Covid, flu vaccine will move to final-stage trial after positive data

GlaxoSmithKline (GSK) has reported promising results from a late-stage clinical trial for its respiratory syncytial virus (RSV) vaccine, Arexvy, in adults aged 50 to 59. The initial findings suggest that GSK’s vaccine may offer protection against RSV to a wider age group, potentially addressing a significant health concern in the older adult population. Arexvy is… Continue reading RSV vaccine from GSK shows potential to protect adults 50 to 59

Appili Therapeutics Inc. (TSX: APLI; OTCQB: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, today announced that the company secured a commitment for the second stage of funding for ATI-1701 from the U.S. Air Force Academy (“USAFA”), who is working in partnership with the Defense Threat… Continue reading Appili Therapeutics’ Biodefense Vaccine Candidate ATI-1701 is Awarded Additional Funding from the U.S. Air Force Academy

Signos, a startup founded in 2018, is taking a novel approach to addressing the obesity epidemic without relying on pills. The company uses off-the-shelf continuous glucose monitors (CGMs) that track glucose levels and are primarily used by people with diabetes. Signos provides real-time diet and exercise recommendations based on an individual’s glucose readings. This data… Continue reading As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data

Amazon is reportedly considering entering the veterinary telehealth sector, a move aimed at competing with Walmart’s pet telehealth service for Walmart+ subscribers. While Amazon already dominates the pet food and supplies market, it has yet to significantly invest in pet health, a sector expected to drive growth in the $137 billion pet market. Veterinary telehealth… Continue reading Amazon considers offering veterinary telehealth as it looks to compete with Walmart

Swiss healthcare company Roche is set to acquire Telavant Holdings in a $7.1 billion deal. Telavant specializes in producing drugs for individuals with inflammatory and fibrotic diseases, with a focus on developing a promising therapy for Crohn’s disease. Roche will gain full rights to the RVT-3101 drug, a treatment under development for inflammatory bowel disease.… Continue reading Swiss pharma giant Roche agrees $7.1 billion deal to buy Telavant Holdings

Toronto, Ontario–(Newsfile Corp. – October 23, 2023) – Justera Health Ltd. (CSE: VTAL) (OTCQB: SCRSF) (“Justera“ or the “Company“) is actively evaluating the possibility of resuming its COVID-19 testing operations, driven by a surge in interest from the film and production industries. As COVID-19 cases continue to surge, the film and production sector has exhibited… Continue reading Justera Evaluating COVID-19 Testing